Alkindo Naratama Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Alkindo Naratama Tbk trades at Rp920 (market cap 2.35T, 143.5K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume). The key difference: Alkindo Naratama Tbk is far larger — about 14.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Alkindo Naratama Tbk is more actively traded (143.5K versus 62.5K). Which is the better fit depends on your goals.
| ALDO | OBAT | |
|---|---|---|
Market Cap | 2.35T | 164.65B |
Volume | 143.5K | 62.5K |
Lot | 1.44K | 625 |
Turnover | 125.62M | 15.03M |
Average Price | 875.4 | 240.55 |
Value | 125.62M | 15.03M |
Indicative Equilibrium Price | 920 | 238 |
Indicative Equilibrium Volume | 55 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Alkindo Naratama Tbk (the "Company") was established based on Notarial Deed No 74 of Kikit Warianti SH, dated January 31, 1989. The Company's Articles of Association have been amended several times. The latest amendment was based on Notarial Deed No. 5 of Nunuy Rahmayati SH dated March 15, 2011 pertaining of Authorized share and paid-up capital, issuance of new share to be offered to the public in the Initial Public Offering, and amendment of the Article of Association of the Company to become a public entity
Read more on ALDO →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →